糖尿病控制与并发症试验/糖尿病干预与并发症流行病学研究(DCCT/EDIC)中的心血管自主神经病变与心血管结局
在DCCT/EDIC队列中,评估DCCT结束时的心血管自主神经病变(CAN)与后续心血管疾病(CVD)事件的关系。DCCT结束时无CAN者1262例中132例(10%)发生244次CVD事件,有CAN者131例中33例(25%)发生55次CVD事件,首次CVD事件风险比为2.79(95%CI 1.91-4.09)。校正包括EDIC更新平均HbA1c在内的多因素后关联仅边缘显著,结论认为该关联并非独立于既往血糖暴露及其代谢记忆效应。
要点
- DCCT结束时合并CAN者随访期间CVD事件累积发生率显著高于无CAN者。
- CAN与首次CVD事件的风险比为2.79(95%CI 1.91-4.09)。
- 校正多因素(含EDIC更新平均HbA1c)后关联仅边缘显著,不独立于血糖暴露。
核心结论
- 在DCCT/EDIC队列中,DCCT结束时诊断为CAN的个体在EDIC随访期间经历更高的长期CVD事件风险。
- 该关联并非独立于既往血糖暴露及其代谢记忆效应,后者是1型糖尿病中长期CVD风险和CAN的主要决定因素。
研究设计与样本
- 在DCCT基线、DCCT期间每2年以及EDIC两个时间点进行标准化心血管自主神经反射试验(包括节律呼吸时R-R反应、Valsalva动作、体位性血压变化)。
- 整个研究期间 ascertain CVD事件并由审查委员会裁定。
- 采用Cox比例风险模型估计DCCT结束时CAN对后续CVD风险的影响。
主要发现
- DCCT结束评估后共发生299次裁定的CVD事件,涉及165名参与者。
- DCCT结束时无CAN者1262例中132例(10%)发生244次CVD事件,有CAN者131例中33例(25%)发生55次CVD事件。
- 首次CVD事件的风险比为2.79(95%CI 1.91-4.09)。
- DCCT结束时合并CAN者EDIC期间任何CVD事件首次发生的累积发生率显著高于无CAN者。
- 校正包括EDIC更新平均HbA1c在内的多因素后关联仅边缘显著;作为连续变量分析时,发生CVD事件者DCCT结束时R-R变异显著低于未发生者(P=0.0012)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine whether cardiovascular autonomic neuropathy (CAN) is an independent risk factor of cardiovascular disease (CVD) events during DCCT/EDIC. RESEARCH DESIGN AND METHODS: Standardized cardiovascular autonomic reflex tests (R-R response to paced breathing, Valsalva maneuver, postural changes in blood pressure) were performed at DCCT baseline, every 2 years throughout DCCT, and at two time points in EDIC. CVD events were ascertained throughout the study and adjudicated by a review committee. Cox proportional hazards models were used to estimate the effect of CAN at DCCT closeout on subsequent CVD risk. RESULTS: There were 299 adjudicated CVD events in 165 participants following the DCCT closeout assessment: 132 of 1,262 subjects (10%) without CAN at DCCT closeout who experienced 244 CVD events versus 33 of 131 subjects (25%) with CAN at DCCT closeout who experienced 55 events (hazard ratio 2.79, 95% CI 1.91-4.09 for time to first CVD event). The cumulative incidence of the first occurrence of any CVD event during EDIC was significantly higher in participants with CAN at DCCT closeout compared with those without CAN. The association remained marginally significant after adjustment for multiple risk factors, including the EDIC updated mean HbA1c. When analyzed as a continuous variable, R-R variation was significantly lower at DCCT closeout in participants who experienced a CVD event compared with those who did not (P = 0.0012). CONCLUSIONS: In the DCCT/EDIC cohort, individuals diagnosed with CAN at DCCT closeout experienced a higher long-term risk of CVD events during follow-up in EDIC. This association was not independent of historic glycemic exposure and its metabolic memory effect, the principal determinant of both long-term CVD risk and CAN in type 1 diabetes.
引用
- Pop-Busui R, Braffett BH, Zinman B, et al. Cardiovascular Autonomic Neuropathy and Cardiovascular Outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study. Diabetes Care. 2016. PMID: 27803120. doi:10.2337/dc16-1397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。